Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from NICE

Donanemab: What is the new Alzheimer’s drug rejected for use on the NHS

Donanemab and another new drug for Alzheimer’s called Lecanemab have been billed as a huge step forward in research

The Independent UK

Decision expected on new Alzheimer’s treatment

The drug is one of the new ‘disease modifying’ treatments for Alzheimer’s disease.

The Independent UK

A dualistic view of illness doesn’t help those with ME/CFS

Letters: Peter White, Trudie Chalder and Michael Sharpe, and Dr Jake Hollis, respond to an article by George Monbiot

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Arsenal legend makes true feelings felt on Manchester United owners

The former Arsenal man has revealed his thoughts on the Manchester United owners following his time under INEOS

FourFourTwo

NHS in England given go-ahead for AI scans to help detect bone fractures

X-ray add-on at estimated £1 a scan aimed at reducing missed diagnoses in initial assessment

The Guardian - UK

I tried CBT for menopause - here are my honest thoughts

CBT for menopause is one of the recommended alternatives to HRT. Here's what happened when writer Laura Williams was prescribed 6 weeks for her symptoms

Woman & Home

Chance for Scotland to lead with Alzheimer’s treatment

SCOTLAND has a “golden opportunity” to lead the way in dementia care if the NHS is given the go-ahead to use a new kind of treatment.

The National (Scotland)

Read news from The Economist, FT, and more,
with one subscription

The Ineos Effect: hit and miss as Jim Ratcliffe’s tentacles have gone global

Ratcliffe has built an empire of assets across different sports but his teams have enjoyed varying degrees of success

The Guardian - UK

Lyme disease: What are the symptoms and how can it be treated?

Lyme Disease UK has warned that the disease is on the rise in the UK

The Independent UK

Mounjaro will soon be available as a weight loss treatment on the NHS – here’s what that means for patients

The weight loss jab Mounjaro will soon be made available to nearly a quarter of a million NHS patients, according to proposals made by the National Institute for Health and Care Excellence (Nice). Previously, it was only available on the NHS for patients with diabetes.

The Conversation

Weight loss drugs shouldn’t create ‘dependency culture’, says Health Secretary

Mr Sweeting said it was in “everyone’s interest to play their part” and avoid overloading the health system.

Evening Standard

The crucial Europa League rule change which could impact Rangers' campaign

The crucial Europa League rule change in revamped league phase which could impact Rangers' campaign.

The National (Scotland)

Ousmane Dembele to Return to PSG Squad vs. Nice, per Report

Ousmane Dembélé reportedly apologized to Luis Enrique and is set to return to PSG's squad against Nice.

Sports Illustrated

Pressure mounts on publisher of Economist over ties to tobacco

Exclusive: Experts pull out of health conferences run by Economist Impact after revelations of commercial links

The Guardian - UK

Get all your
news in one place.

100’s of premium titles.
One news app.

Tom’s Guide

NYT Connections today hints and answers — Thursday, September 19 (#466)

Need help with Connections #466? Here are some hints and the answers.

The Guardian - UK

Ten of the best-value deals from this summer’s transfer window

Close to £5bn was spent by Europe’s top five men’s leagues – but which players may prove to be worth the fees paid?

FourFourTwo

Europa League and Conference League draw: As they happened

The Europa League and Conference League have drawn some fantastic fixtures for the league stage of the competition

FourFourTwo

Every footballer to have received a perfect 10 from L’Equipe: featuring Lionel Messi, Ademola Lookman and Neymar

Only 15 players in football history have achieved a perfect 10/10 match rating from the prestigious publication.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

UK drug regulator approves Alzheimer's drug but government likely won't pay for it

Britain’s drug regulator has authorized the Alzheimer’s drug Leqembi, saying that it’s the first medicine to show some impact in slowing progression of the neurodegenerative disease

The Independent UK

What you need to know about lecanemab – the Alzheimer’s drug rejected for NHS use

The drug has been developed by Eisai, a Japanese pharmaceutical company, and is sold under the brand name Leqembi

Evening Standard

What is Lecanemab and who makes it? Alzheimer’s drug gets approval but will not be available on the NHS

NICE says drug is not cost effective and shares fears of side effects

The Independent UK

First drug to slow Alzheimer’s progression will not be made available on the NHS

The spending watchdog has recommended that a drug shown to slow the progression of Alzheimer’s disease should not be rolled out on the NHS.

The Guardian - UK

UK health regulator rejects lecanemab as treatment for Alzheimer’s

Decision by Nice to rule out drug being available on NHS comes despite medicines licensing body giving green light

The Guardian - UK

Women in England to be offered a daily tablet for fibroids, Nice says

About 30,000 patients with moderate to severe symptoms could receive Linzagolix, which may shrink growths

The Independent UK

One third of NHS psychosis services used to treat patients like Valdo Calocane are failing standards

Health minister Wes Streeting said Barnaby Webber, Grace O’Malley-Kumar and Ian Coates “might still be alive” today if “the NHS had been there when it should have been”

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

UEFA Champions League

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.